Dezhan Healthcare Company Limited (000813.SZ) Bundle
Who is buying Dezhan Healthcare (000813.SZ) and why it matters: a closer look at the cap table reveals concentrated backing and broad retail interest-most strikingly Xinjiang Kaidi Investment Co., Ltd.'s 19.5% stake (409,748,445 shares, valued at CN¥1.9 billion), alongside public ownership of 58.1% (1,218,255,142 shares) that fuels liquidity and volatility, while private companies (13.8%) and venture capital/private equity (also 19.5%, 409,748,445 shares) signal substantial non‑retail conviction; notable holders include Mylin Resources Group at 8.87% (186,038,682 shares, CN¥842.8 million), Wenlong Chenzhi at 5.22% (109,500,000 shares, CN¥496.0 million), and Xinjiang Kaidi Mining Investment Co., Ltd. at 4.96% (104,039,367 shares, CN¥471.3 million), with institutional investors relatively muted (institutions ~2.45%, 51,294,646 shares and the largest institutional holder China Southern Asset Management at 0.01%, 12,299,900 shares); juxtapose this ownership profile with operational signals-a turnaround to net income of CN¥10.1526 million in H1 2024 and the establishment of a Science and Technology Innovation Development Center in July 2025-to understand how strategic shareholders, retail dominance, and modest institutional participation could shape Dezhan's next phase and why investors are taking positions now-read on to unpack the implications for governance, strategy, and market sentiment.
Dezhan Healthcare Company Limited (000813.SZ) - Who Invests in Dezhan Healthcare Company Limited (000813.SZ) and Why?
Major strategic, institutional and individual investors hold concentrated positions in Dezhan Healthcare, signaling both regional strategic ties and confidence in the company's growth trajectory. Key investors combine long-term strategic aims, portfolio diversification, and direct personal conviction.
- Xinjiang Kaidi Investment Co., Ltd. - strategic anchor investor aligning regional industrial capital with Dezhan Healthcare's expansion plans.
- Mylin Resources Group - financial investor expressing confidence in market positioning and revenue potential.
- Wenlong Chenzhi - significant personal stake indicating insider/management alignment with shareholder value creation.
- Xinjiang Kaidi Mining Investment Co., Ltd. - intra-group diversification across related Xinjiang Kaidi entities.
- Xinjiang Financial Investment (Group) Co., Ltd. - institutional endorsement reflecting risk/return conviction.
- Le Sheng Cao - notable individual investor likely motivated by long-term upside expectation.
| Investor | Ownership (%) | Shares Held | Estimated Value (CN¥) | Investment Rationale |
|---|---|---|---|---|
| Xinjiang Kaidi Investment Co., Ltd. | 19.50% | 409,748,445 | 1,900,000,000 | Strategic growth partner - large anchor stake for regional industrial integration. |
| Mylin Resources Group | 8.87% | 186,038,682 | 842,800,000 | Financial investor confident in Dezhan's market position and returns. |
| Wenlong Chenzhi | 5.22% | 109,500,000 | 496,000,000 | Significant personal stake - alignment with company performance. |
| Xinjiang Kaidi Mining Investment Co., Ltd. | 4.96% | 104,039,367 | 471,300,000 | Group-level diversification within Xinjiang Kaidi investment vehicles. |
| Xinjiang Financial Investment (Group) Co., Ltd. | 1.09% | 22,801,946 | 103,300,000 | Institutional endorsement - confidence in strategic outlook. |
| Le Sheng Cao | 0.87% | 18,219,258 | 82,500,000 | Notable individual investment expecting long-term appreciation. |
- Collective weight: these named holders represent a concentrated ownership base providing stability and potential strategic direction for Dezhan Healthcare.
- Capital at stake: the six investors account for over CN¥3.9 billion in combined share value (sum of listed valuations), underscoring meaningful financial commitment.
- Implication for investors: strategic group support from Xinjiang entities plus institutional and individual stakes suggest both regional strategic alignment and diversified investor confidence.
Further context on company purpose and guiding principles can be found here: Mission Statement, Vision, & Core Values (2026) of Dezhan Healthcare Company Limited.
Institutional Ownership and Major Shareholders of Dezhan Healthcare Company Limited (000813.SZ)
Dezhan Healthcare Company Limited (000813.SZ) exhibits a shareholder base dominated by retail and private/VC investors, with relatively limited direct participation from institutional asset managers. The numbers below frame who's buying and the scale of their stakes.- Institutional investors (collective): 2.45% - 51,294,646 shares (aggregate).
- Largest institutional holders highlighted: China Southern Asset Management Co., Ltd. and China Asset Management Co., Ltd.
- General public (retail): 58.1% - 1,218,255,142 shares.
- Private companies: 13.8% - 290,078,049 shares.
- Venture capital & private equity: 19.5% - 409,748,445 shares.
| Holder Type / Name | Shares | Percent Ownership | Reported/Estimated Value (CN¥) |
|---|---|---|---|
| Institutional investors (total) | 51,294,646 | 2.45% | ≈ CN¥232.3 million (estimated) |
| China Southern Asset Management Co., Ltd. | 12,299,900 | 0.01% | CN¥55.7 million (reported) |
| China Asset Management Co., Ltd. | 6,897,200 | 0.33% | CN¥31.2 million (reported) |
| General public (retail) | 1,218,255,142 | 58.1% | ≈ CN¥5.52 billion (estimated) |
| Private companies | 290,078,049 | 13.8% | ≈ CN¥1.31 billion (estimated) |
| Venture capital & private equity | 409,748,445 | 19.5% | ≈ CN¥1.86 billion (estimated) |
- Note on valuation: reported values for China Southern and China Asset imply a per-share price ≈ CN¥4.53; the table uses that price to estimate broader segment market values.
- Implication for investors: institutional ownership is modest (2.45%), while retail, private companies and VC/PE constitute the bulk of the free float and control dynamics.
Dezhan Healthcare Company Limited (000813.SZ) Key Investors and Their Impact on Dezhan Healthcare Company Limited
Major shareholders shape corporate strategy, board composition, financing capacity and M&A appetite. The following breakdown highlights who holds meaningful stakes in Dezhan Healthcare Company Limited (000813.SZ) and what each investor's position implies for governance, strategy and stability.
- Xinjiang Kaidi Investment Co., Ltd. - 19.50%: largest single shareholder with near-blocking influence over ordinary resolutions and strong sway on board appointments and strategic direction.
- Mylin Resources Group - 8.87%: a significant strategic/institutional holder whose position signals commercial confidence and potential for partnership or resource support.
- Wenlong Chenzhi - 5.22%: meaningful insider/personal holding level that aligns managerial interests with shareholder value and can influence internal decisions.
- Xinjiang Kaidi Mining Investment Co., Ltd. - 4.96%: a related-party stake that suggests coordinated holdings within the Kaidi group, enabling cross-company collaboration or preferential transactions.
- Xinjiang Financial Investment (Group) Co., Ltd. - 1.09%: an institutional minority stake that provides additional credibility and potential access to financing or regional policy channels.
- Le Sheng Cao - 0.87%: a notable individual investor whose participation adds to insider alignment and retail/institutional confidence.
| Investor | Reported Ownership (%) | Type | Direct Strategic Influence | Likely Impact on Dezhan Healthcare |
|---|---|---|---|---|
| Xinjiang Kaidi Investment Co., Ltd. | 19.50 | Corporate (Major Shareholder) | High (near 20% block) | Controls strategic decisions, board appointments, M&A stance; can facilitate capital access and group synergies. |
| Mylin Resources Group | 8.87 | Corporate / Institutional | Moderate | Signals confidence; potential partner for commercial or supply-chain agreements; supportive in shareholder votes. |
| Wenlong Chenzhi | 5.22 | Individual / Insider | Moderate | Aligns management/shareholder interests; can influence governance and operational priorities. |
| Xinjiang Kaidi Mining Investment Co., Ltd. | 4.96 | Corporate (Related party) | Moderate | Part of Kaidi group aggregation - potential for inter-company collaboration and resource sharing. |
| Xinjiang Financial Investment (Group) Co., Ltd. | 1.09 | Institutional | Low | Adds institutional credibility and may support financing or regional policy engagement. |
| Le Sheng Cao | 0.87 | Individual | Low | Minor but notable personal investment; contributes to insider ownership profile. |
Ownership concentration and the presence of related-party holdings (Xinjiang Kaidi affiliates totaling 24.46% when combining the 19.50% and 4.96% stakes) are particularly relevant to governance analysis, voting dynamics and potential strategic alignment across group companies. Close monitoring of any changes in these stakes-especially the 19.5% position-helps anticipate shifts in strategic priority, capital allocation and potential transactions.
Mission Statement, Vision, & Core Values (2026) of Dezhan Healthcare Company Limited.
Dezhan Healthcare Company Limited (000813.SZ) Market Impact and Investor Sentiment
Dezhan Healthcare's ownership structure and recent financial turnaround are shaping market impact and investor sentiment across retail, private, and institutional channels. The mix of significant private and venture capital holdings, a large public float, and limited institutional ownership creates a dynamic environment for share price discovery, liquidity, and perceived risk.- Major shareholders: Xinjiang Kaidi Investment Co., Ltd. is a principal stakeholder, exerting strategic influence on corporate direction and signaling confidence to some market participants.
- Private companies & venture capital: sizable stakes held by private/VC investors suggest conviction in medium- to long-term growth prospects and can attract follow-on capital.
- Institutional ownership: relatively low institutional participation implies cautious sentiment from funds and asset managers, possibly reflecting concerns about governance, volatility, or sector risk.
- Public/retail ownership: a substantial retail base increases trading liquidity but can amplify short-term volatility during news or earnings events.
| Metric | Value / Detail |
|---|---|
| Stock code | 000813.SZ |
| H1 2024 net income | ¥10.1526 million (turned profit YoY) |
| Major shareholder (example) | Xinjiang Kaidi Investment Co., Ltd. - large strategic stake |
| Ownership composition (illustrative) | Private companies & VCs ~35% | Institutional investors ~12% | Public/retail ~53% |
| Key corporate development | Science and Technology Innovation Development Center established July 2025 |
- Positive earnings momentum: H1 2024 net income of ¥10.1526 million-transition from loss to profit-supports a bullish narrative among growth-focused investors.
- Innovation commitment: the July 2025 launch of a Science and Technology Innovation Development Center reinforces the growth story and may improve confidence among R&D-oriented investors and VCs.
- Concentrated strategic ownership: large private/strategic shareholders can provide stability and access to capital but may also limit free-float and deter some institutional buyers seeking greater diversification.
- Retail-driven liquidity: high public ownership boosts daily volume and price discovery but increases sensitivity to news, social sentiment, and short-term trading flows.
- Potential for increased inbound investment if private/VC holders lead follow-on rounds or partnerships, leveraging the company's improved profitability and new innovation center.
- Continued cautious stance by institutional investors could cap valuation multiples until governance, transparency, or scale metrics improve.
- Elevated volatility risk due to large retail participation; earnings beats or operational milestones may produce outsized moves.
Dezhan Healthcare Company Limited (000813.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.